Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs SWHFX overlap: 76% of top holdings shared

Bottom line

How much do XLV and SWHFX overlap?

76% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 72.9% of XLV's assets and 60.7% of SWHFX's. They are largely the same portfolio — owning both adds little diversification.

Updated Nov 22, 2026

Overlap at a glance

XLVSWHFX
Weight overlap (top 25)76%
Shared holdings17
Weight in shared holdings72.9%60.7%
Total positions6580
Expense ratio0.08%0.8%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XLV and SWHFX have in common

Holding% of XLV% of SWHFXOverlap
Eli Lilly & Co16.51%13.92%13.92%
Johnson & Johnson10.64%6.94%6.94%
AbbVie Inc7.74%5.81%5.81%
UnitedHealth Group Inc6.57%4.74%4.74%
Merck & Co Inc5.52%4.98%4.98%
Amgen Inc3.40%2.58%2.58%
Thermo Fisher Scientific Inc3.24%2.16%2.16%
Abbott Laboratories2.75%1.60%1.60%
Gilead Sciences Inc2.73%3.24%2.73%
Vertex Pharmaceuticals Inc2.19%1.89%1.89%
Danaher Corp2.09%1.47%1.47%
Bristol-Myers Squibb Co2.05%2.44%2.05%
Stryker Corp1.89%2.11%1.89%
Medtronic PLC1.75%2.29%1.75%
Elevance Health Inc1.46%1.45%1.45%
Cigna Group/The1.27%1.51%1.27%
Boston Scientific Corp1.10%1.60%1.10%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Intuitive Surgical Inc — 2.45%
  2. Pfizer Inc — 2.39%
  3. CVS Health Corp — 2.30%
  4. McKesson Corp — 1.58%
  5. Regeneron Pharmaceuticals Inc — 1.08%
  6. HCA Healthcare Inc — 1.05%
  7. Cardinal Health Inc — 0.97%
  8. Cencora Inc — 0.96%

Only in SWHFX

  1. Novartis AG — 2.92%
  2. Roche Holding AG — 2.29%
  3. Gsk Plc — 1.73%
  4. Incyte Corp — 1.37%
  5. Ipsen SA — 1.34%
  6. Sanofi SA — 1.31%
  7. Becton Dickinson & Co — 1.24%
  8. Astellas Pharma Inc — 1.19%

Asset mix

Asset typeXLVSWHFX
Stocks99.7%99.0%
Cash & short-term funds0.3%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXLVSWHFX
US97.9%78.6%
CH—5.2%
IE2.1%4.5%
GB—3.4%
FR—2.6%
JP—2.3%
DK—0.7%
NL—0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XLV and SWHFX overlap?
About 76% by weight. 17 securities appear in both funds' top 25 holdings; they make up 72.9% of XLV's assets and 60.7% of SWHFX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do XLV and SWHFX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, UnitedHealth Group Inc.
Should I own both XLV and SWHFX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, XLV or SWHFX?
SWHFX is broader, with 80 positions versus 65 for XLV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.